Abstract

Aim. In the present study, we investigated the protective effect of genistein in experimental acute liver damage induced by CCl4. Method. Forty rats were equally allocated to 5 groups. The first group was designated as the control group (group 1). The second group was injected with intraperitoneal CCl4 for 3 days (group 2). The third group was injected with subcutaneous 1 mg/kg genistein for 4 days starting one day before CCl4 injection. The fourth group was injected with intraperitoneal CCl4 for 7 days. The fifth group was injected with subcutaneous 1 mg/kg genistein for 8 days starting one day before CCl4 injection. Plasma and liver tissue malondialdehyde (MDA) and liver glutathione levels, as well as AST and ALT levels were studied. A histopathological examination was conducted. Results. Liver tissue MDA levels were found significantly lower in group 3, in comparison to group 2 (P<.05). Liver tissue MDA level in group 5 was significantly lower than that in group 4 (P<.001). Liver tissue glutathione levels were higher in group 5 and 3, relative to groups 4 and 2, respectively (P>.05 for each). Inflammation and focal necrosis decreased in group 3, in comparison to group 2 (P<.001 for each). Inflammation and focal necrosis in group 5 was lower than that in group 4 (P<.001). Actin expression decreased significantly in group 5, relative to group 4 (P<.05). Conclusion. Genistein has anti-inflammatory and antinecrotic effects on experimental liver damage caused by CCl4. Genistein reduces liver damage by preventing lipid peroxidation and strengthening antioxidant systems.